UP FRONT
ASH Directions
High-Cost and
High-Demand
New ASH Drug Access Web Page Provides
Resources for Clinicians and Patients
Hematologic drugs are expensive and often available only in
specialty tiers of prescription drug plans – presenting several barriers to access. To help ensure patient access to safe and effective
hematologic drugs, ASH recently launched a Drug Resources
Web page (hematology.org/Clinicians/Drugs).
The Web page provides a consolidated list of resources to
keep physicians informed of newly approved therapies, safety and
prescription matters, shortages of critical hematologic drugs, and
ways to access high-cost hematologic drugs for patients. Read on
to learn more about the program and how clinicians can utilize
this resource in their own practices.
ASH’s Drug Access Web page
(hematology.org/Clinicians/Drugs)
High-Cost Hematologic Drug Access
In all areas of medicine, high drug prices are a major issue facing
patients, but the cost of treatment is particularly burdensome for
patients with hematologic conditions such as leukemia, lymphoma, and hemophilia.
After being notified of the problem of high-cost drugs by the
Committee on Practice, ASH staff reached out to the practice
community to learn about the impact of drug costs on patient care.
The findings were presented at the Executive Committee 2014 May
Retreat, and the result of these discussions was the development of
an ASH hi